Latest news with #lifestylediseases
The Independent
16-07-2025
- Health
- The Independent
Beloved Indian snacks to soon carry health warnings
The Indian government is implementing health warnings for popular snacks like samosas and jalebis to be displayed as cautionary notices in public venues. These warnings are intended to make people aware of hidden oil, sugar and trans-fat content in food products, rather than being placed directly on the snack items themselves. The initiative stems from growing concerns over India 's escalating burden of lifestyle diseases, including diabetes, hypertension, and cardiovascular conditions. Health experts largely support the move, drawing parallels between the health risks of sugar and trans fats and those of tobacco. However, the policy has drawn criticism from nutritionists and public figures who argue it unfairly targets traditional Indian foods while neglecting ultra-processed Western alternatives.
Yahoo
19-06-2025
- Business
- Yahoo
Human Microbiome Market Forecasts Report 2025-2030: Key Insights for Navigating Emerging Opportunities
The human microbiome market is projected to expand at a CAGR of 20.42%, growing from $941.215 million in 2025 to $2.38 billion by 2030. This growth is driven by rising lifestyle diseases, an aging populace, and biomedical tech advances. Challenges include low awareness and government restrictions. The comprehensive report explores market trends, technological advancements, and regulatory impacts, featuring key players like Seres Therapeutics and Ferring Pharmaceuticals. It's essential for businesses targeting market entry, opportunity assessment, and strategic decision-making. Human Microbiome Market Dublin, June 19, 2025 (GLOBE NEWSWIRE) -- The "Human Microbiome Market - Forecasts from 2025 to 2030" has been added to offering. The global human microbiome market is projected to expand at a robust CAGR of 20.42%, reaching approximately US$2.38 billion by 2030, up from US$941.215 million in 2025. This growth is primarily driven by escalating cases of lifestyle diseases, an increase in diarrheal infections, significant lifestyle shifts across populations, and a growing elderly demographic. The market also benefits from advancing technology in biomedical sciences and increased investment in research. Despite these positives, challenges such as insufficient awareness about prebiotics and probiotics and regulatory constraints pose significant obstacles for key market players. Market Trends: Comprehensive Market Analysis: The global human microbiome market report offers an exhaustive examination of the sector, providing valuable insights and data-backed forecasts essential for strategic planning and understanding the market trajectory. Strategic Insights for Decision-makers: Updated regularly, the report provides crucial intelligence on market trends, emergent opportunities, and competitive dynamics. It delves into consumer demand across therapeutics, diagnostics, and probiotics, analyzing purchasing behaviors and key segments like healthcare providers, pharmaceutical companies, and consumers. Technological and Regulatory Exploration: The report investigates advancements such as next-generation sequencing and microbiome-based drug innovations, while also reviewing the regulatory landscape including policies on personalized medicine. This helps stakeholders strategize effectively in a rapidly advancing market. Key Benefits of this Report: Insightful Analysis: Comprehensive insights covering major and emergent geographical markets, focusing on consumer segments, governmental policies, and industry verticals. Competitive Landscape: Analysis of strategies employed by key players to guide market entry and growth tactics. Market Drivers & Future Trends: An exploration of market dynamics and trends shaping the industry's future. Actionable Recommendations: Leverage insights for strategic decisions, uncovering new business opportunities in a dynamic environment. Diverse Audience: Useful for startups, research institutions, consultants, SMEs, and large enterprises. Report Coverage: Data from 2022 to 2024 with forecasts from 2025 to 2030 Growth opportunities, challenges, supply chain outlook, regulatory framework, and trends Competitive positioning, strategies, and market share analysis Revenue growth forecast for segments and regions, including countries Company Profiling: Strategies, Product Offerings, Financial Data, and Developments Seres Therapeutics Microbiome Therapeutics Innovation Group Vedanta Biosciences Inc. Metabiomics Ferring Pharmaceuticals Finch Therapeutics BiomeBank Biohm Technologies Resbiotic Immuron Limited Maat Pharma Market Segmentation: Product Categories: Probiotic, Prebiotics, Supplements, Others Disease Categories: Diabetes, Autoimmune Disorder, Cancer, Obesity, Others Application Categories: Diagnostics, Therapeutics Regional Coverage: North America, South America, Europe, Middle East and Africa, Asia Pacific Key Attributes: Report Attribute Details No. of Pages 148 Forecast Period 2025 - 2030 Estimated Market Value (USD) in 2025 $941.22 Million Forecasted Market Value (USD) by 2030 $2380 Million Compound Annual Growth Rate 20.4% Regions Covered Global For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Human Microbiome Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio
